Dr Pauline Pradere
Saskia Bos
Dr Andre Pozza
Dr Gerard Meachery
Dr James Lordan
et al. | Outcomes of listing for lung and heart–lung transplantation in pulmonary hypertension: comparative experience in France and the UK | 2024 |
|
Dr James Lordan
Dr Moha Shojaei
Dr Nan Lin
Professor James Wason
| Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies | 2024 |
|
Dr James Lordan
| Sendaway capillary NT-proBNP in pulmonary hypertension | 2024 |
|
Dr James Lordan
| A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex | 2023 |
|
Dr James Lordan
| Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control | 2023 |
|
Saskia Bos
Dr James Lordan
Dr Arun Nair
Professor Andrew Fisher
Dr Gerard Meachery
et al. | Lung transplantation for interstitial lung disease: evolution over three decades | 2023 |
|
Dr James Lordan
| Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes | 2022 |
|
Dr James Lordan
| Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension | 2022 |
|
Dr James Lordan
| Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension | 2021 |
|
Dr James Lordan
| Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood | 2021 |
|
Dr James Lordan
| Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement | 2021 |
|
Dr James Lordan
| A European Multi-Center, Randomized, Double-Blind Trial of Pirfenidone in Bronchiolitis-Obliterans-Syndrome Grade 1-3 in Lung Transplant Recipients (European Trial of Pirfenidone in BOS (EPOS)) | 2020 |
|
Professor Andrew Fisher
Dr James Lordan
| Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? | 2020 |
|
Dr James Lordan
| Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: An interventional open-label study | 2019 |
|
Professor Christopher Ward
Dr Gerard Meachery
Dr James Lordan
Professor Andrew Fisher
| Long-term effect of azithromycin in bronchiolitis obliterans syndrome | 2019 |
|
Dr James Lordan
| Patient outcomes from time of listing for lung transplantation in the UK: Are there disease-specific differences? | 2019 |
|
Eleni Sofianopoulou
Dr James Lordan
| Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis | 2019 |
|
Professor Christopher Ward
Professor Jeffrey Pearson
Dr James Lordan
Professor Anthony De Soyza
| A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk | 2018 |
|
Dr James Lordan
| A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial | 2018 |
|
Dr Jodie Birch
Dr Katy Hester
Dr Gareth Parry
Professor Kate Gould
Professor John Dark
et al. | Outcomes of lung transplantation in adults with bronchiectasis | 2018 |
|
Sasiharan Sithamparanathan
Dr Logan Thirugnanasothy
Professor Andrew Fisher
Dr James Lordan
| Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry | 2017 |
|
Dr James Lordan
| The CRASH report: Emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension | 2017 |
|
Dr James Lordan
| Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK) | 2016 |
|
Dr James Lordan
| A combination of two novel alpha globin variants Hb Bridlington (HBA1) and Hb Taybe (HBA2) resulting in severe hemolysis, pulmonary hypertension, and death | 2015 |
|
Dr Malcolm Brodlie
Ali Aseeri
Dr James Lordan
Dr Andrew Robertson
Dr Michael McKean
et al. | Bile acid aspiration in people with cystic fibrosis before and after lung transplantation | 2015 |
|
Monika Suwara
Dr Bart Vanaudenaerde
Dr Nicola Green
Professor Christopher Ward
Dr Lee Borthwick
et al. | Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation | 2014 |
|
Dr James Lordan
Professor Andrew Fisher
| Functional and Quality of Life Improvements in Treated Patients with Chronic Thromboembolic Pulmonary Hypertension | 2013 |
|
Dr Laura Mackay
Dr James Lordan
Professor Andrew Fisher
| Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema | 2013 |
|
Professor Christopher Ward
Dr James Lordan
Dr Robert Rutherford
| Non-cystic fibrosis bronchiectasis | 2013 |
|
Professor Andrew Fisher
Dr James Lordan
| Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland | 2012 |
|
Dr Clare Burdett
Dr James Lordan
Professor John Dark
Stephen Clark
| Comparison of single lung transplant with and without the use of cardiopulmonary bypass | 2012 |
|
Dr Malcolm Brodlie
Dr James Lordan
Professor Christopher Ward
| Interleukin-17 and Cystic Fibrosis Lung Disease | 2012 |
|
Dr John Perry
Dr Gerard Meachery
Dr James Lordan
Professor Andrew Fisher
Professor Kate Gould
et al. | Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing | 2012 |
|
Dr James Lordan
| Pulmonary arterial hypertension and lung transplantation | 2011 |
|
Dr Nigel Kirkham
Dr James Lordan
Professor Andrew Fisher
| Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension | 2011 |
|
Dr Venetia Bigley
Dr Xiao Wang
Dr Rachel Dickinson
Dr Naomi McGovern
Sarah Pagan
et al. | The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency | 2011 |
|
Dr Malcolm Brodlie
Dr Michael McKean
Dr Joseph Gray
Professor Andrew Fisher
Dr James Lordan
et al. | Ceramide is Increased in the Lower Airway Epithelium of People with Advanced Cystic Fibrosis Lung Disease | 2010 |
|
Dr Lee Borthwick
Marta Gorowiec
Dr Malcolm Brodlie
Professor Christopher Ward
Dr James Lordan
et al. | Inflammation and Epithelial to Mesenchymal Transition in Lung Transplant Recipients: Role in Dysregulated Epithelial Wound Repair | 2010 |
|
Professor Anthony De Soyza
Dr Gerard Meachery
Dr Katy Hester
Anne Nicholson
T Pillay
et al. | Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience | 2010 |
|
Professor Christopher Ward
Julie Diboll
Professor Andrew Fisher
Dr Malcolm Brodlie
Dr James Lordan
et al. | Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells | 2009 |
|
Professor Christopher Ward
Professor Jeffrey Pearson
Therese Small
Dr James Lordan
Professor Andrew Fisher
et al. | Longitudinal changes in gastro-oesophageal reflux from 3 months to 6 months after lung transplantation | 2009 |
|
Professor Anthony De Soyza
Dr James Lordan
Professor Andrew Fisher
Professor John Dark
Professor Kate Gould
et al. | Outcomes of lung transplantation for cystic fibrosis in a large UK cohort | 2008 |
|
